PCM
TMCI icon

Peregrine Capital Management’s Treace Medical Concepts TMCI Stock Holding History

Peregrine Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-280,091
Closed -$7.16M – 327
2023
Q2 		$7.16M Sell
280,091
-87
-0% -$2.25K 0.19% 216
2023
Q1 		$7.06M Buy
+280,178
New +$6.58M 0.2% 213

Other funds holding TMCI

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Peregrine Capital Management's TMCI Position: Q3 2023 in Review

Peregrine Capital Management sold out of Treace Medical Concepts (TMCI) in Q3 2023, closing a stake of 280,091 shares — an estimated $7.16M sold.

Peregrine Capital Management first reported a position in TMCI in Q1 2023 and held it in 2 quarters. The position peaked at $7.16M in Q2 2023. 123 funds tracked by Wall St. Rank hold TMCI as of Q3 2023.

  • Peregrine Capital Management reported no remaining Treace Medical Concepts position as of Q3 2023 after selling out during the quarter.
  • Peregrine Capital Management sold 280,091 Treace Medical Concepts shares in Q3 2023, an estimated $7.16M.
  • Peregrine Capital Management first reported a position in Treace Medical Concepts in Q1 2023 and held it in 2 quarters.
  • Peregrine Capital Management's Treace Medical Concepts position peaked at $7.16M in Q2 2023.
  • 123 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2023.

Based on Peregrine Capital Management's 13F filing for Q3 2023, filed 19 Oct 2023.